Actively Recruiting
Blood Cell RNA-Based Cancer Detection
Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2024-07-24
5000
Participants Needed
1
Research Sites
199 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Early diagnosis of cancer may provide patients with more treatment options and hopefully prolong survival. The purpose of this multi-center study is to collect peripheral blood from newly diagnosed cancer patients and healthy donors to establish a blood cell RNA-based model for the differentiation of cancer patients and healthy donors. The area under the receiver operating characteristic (AUROC), sensitivity and specificity of the test in the early detection of multiple cancers will be measured.
CONDITIONS
Official Title
Blood Cell RNA-Based Cancer Detection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Provide informed consent
You will not qualify if you...
- Pregnancy or lactating women
- Received a blood transfusion within 1 month
- Received anti-cancer treatment within 3 years
- Known prior diagnosis of cancer
- Poor health status or unfit to tolerate blood draw
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zheng Wang
Wuhan, Hubei, China, 430022
Actively Recruiting
Research Team
Z
Zheng Wang, MD/PhD
CONTACT
L
Luming Xu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here